Personal tools

Skip to content. | Skip to navigation

You are here: Home Find A Doctor Gerald W. Dryden, M.D., MSPH, M.Sc.
Department of Medicine

Gerald W. Dryden, M.D., MSPH, M.Sc.

by Puckett,Paul J last modified Mar 25, 2013 03:39 PM


Gerald W. Dryden, M.D., MSPH, M.Sc.






Gerald W. Dryden, M.D., MSPH, M.Sc.

  • Associate Professor of Medicine
University of Louisville Health Care Outpatient Center
401 East Chestnut Street, Ste. 310
Louisville, KY 40202

502-852-7963 - Academic Office
502-813-6500 - Patient Appointments





ULP Digestive & Liver Health

Clinical Expertise

Hepatology; Inflammatory Bowel Disease; Endoscopic Device Development

 

Board Certifications

  • American Board of Internal Medicine - Gastroenterology


Education and Training

  • Medical School: University of Kentucky

  • Residency: Naval Medical Center, Portsmouth, Va.

  • Fellowship: Naval Medical Center, San Diego, Calif.

  • MSPH: University of Louisville


Recent Publications

  • Schiffman SC, Li Y, Dryden G, Li X, Martin RC. Positive correlation of image analysis by mini-endoscopy with micro-PET scan and histology in rats after esophagoduodenal anastomosis. Surg Endosc. 2010 Nov;24(11):2835-41. doi: 10.1007/s00464-010-1059-1. Epub 2010 May 4. PubMed PMID: 20440518.

  • Sands BE, Jacobson EW, Sylwestrowicz T, Younes Z, Dryden G, Fedorak R, Greenbloom S. Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohn's disease. Inflamm Bowel Dis. 2010 Jul;16(7):1209-18. doi: 10.1002/ibd.21159. PubMed PMID: 19918967.

  • Dryden GW Jr. Overview of biologic therapy for Crohn's disease. Expert Opin Biol Ther. 2009 Aug;9(8):967-74. doi: 10.1517/14712590903048909. Review. PubMed PMID: 19591627.

  • Dryden GW. Overview of stem cell therapy for Crohn's disease. Expert Opin Biol Ther. 2009 Jul;9(7):841-7. doi: 10.1517/14712590902956615. Review. PubMed PMID: 19527107.

  • Harrell SP, Studts JL, Dryden GW, Eversmann J, Cai L, Wo JM. A novel classification scheme for gastroparesis based on predominant-symptom presentation. J Clin Gastroenterol. 2008 May-Jun;42(5):455-9. doi: 10.1097/MCG.0b013e31815ed084. PubMed PMID: 18344894.

  • Dryden GW. Natalizumab for Moderate-to-Severe Crohn's Disease. Gastroenterol Hepatol (N Y). 2008 Apr;4(4):296. PubMed PMID: 21960916; PubMed Central PMCID: PMC3093736.

  • Dryden GW, Song M, McClain C. Polyphenols and gastrointestinal diseases. Curr Opin Gastroenterol. 2006 Mar;22(2):165-70. Review. PubMed PMID: 16462174.

  • Dryden GW Jr, Deaciuc I, Arteel G, McClain CJ. Clinical implications of oxidative stress and antioxidant therapy. Curr Gastroenterol Rep. 2005 Aug;7(4):308-16. Review. PubMed PMID: 16042916.

  • Krueger KJ, McClain CJ, McClave SA, Dryden GW. Nutritional supplements and alternative medicine. Curr Opin Gastroenterol. 2004 Mar;20(2):130-8. PubMed PMID: 15703634.

  • Jabbar A, Chang WK, Dryden GW, McClave SA. Gut immunology and the differential response to feeding and starvation. Nutr Clin Pract. 2003 Dec;18(6):461-82. PubMed PMID: 16215082.

Document Actions
Personal tools